ReviewFrontiers in immunology2026

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment.

Timothy Paul Hickling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.